-
1
-
-
0033753779
-
The DNA methyltransferases of mammals
-
Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000, 9:2395-2402.
-
(2000)
Hum. Mol. Genet.
, vol.9
, pp. 2395-2402
-
-
Bestor, T.H.1
-
2
-
-
66749152204
-
Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids
-
Iyer L.M., Tahiliani M., Rao A., Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 2009, 8:1698-1710.
-
(2009)
Cell Cycle
, vol.8
, pp. 1698-1710
-
-
Iyer, L.M.1
Tahiliani, M.2
Rao, A.3
Aravind, L.4
-
3
-
-
66149146320
-
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1
-
Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
-
(2009)
Science
, vol.324
, pp. 930-935
-
-
Tahiliani, M.1
Koh, K.P.2
Shen, Y.3
Pastor, W.A.4
Bandukwala, H.5
Brudno, Y.6
Agarwal, S.7
Iyer, L.M.8
Liu, D.R.9
Aravind, L.10
Rao, A.11
-
4
-
-
66149123748
-
The nuclear DNA base 5-hydroxymethylcytosine is present in purkinje neurons and the brain
-
Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in purkinje neurons and the brain. Science 2009, 324:929-930.
-
(2009)
Science
, vol.324
, pp. 929-930
-
-
Kriaucionis, S.1
Heintz, N.2
-
5
-
-
79956302047
-
TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity
-
Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A., Rappsilber J., Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
-
(2011)
Nature
, vol.473
, pp. 343-348
-
-
Williams, K.1
Christensen, J.2
Pedersen, M.T.3
Johansen, J.V.4
Cloos, P.A.5
Rappsilber, J.6
Helin, K.7
-
6
-
-
79956292024
-
Dual functions of TET1 in transcriptional regulation in mouse embryonic stem cells
-
Wu H., D'Alessio A.C., Ito S., Xia K., Wang Z., Cui K., Zhao K., Sun Y.E., Zhang Y. Dual functions of TET1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011, 473:389-393.
-
(2011)
Nature
, vol.473
, pp. 389-393
-
-
Wu, H.1
D'Alessio, A.C.2
Ito, S.3
Xia, K.4
Wang, Z.5
Cui, K.6
Zhao, K.7
Sun, Y.E.8
Zhang, Y.9
-
7
-
-
79956308473
-
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells
-
Pastor W.A., Pape U.J., Huang Y., Henderson H.R., Lister R., Ko M., McLoughlin E.M., Brudno Y., Mahapatra S., Kapranov P., Tahiliani M., Daley G.Q., Liu X.S., Ecker J.R., Milos P.M., Agarwal S., Rao A. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 2011, 473:394-397.
-
(2011)
Nature
, vol.473
, pp. 394-397
-
-
Pastor, W.A.1
Pape, U.J.2
Huang, Y.3
Henderson, H.R.4
Lister, R.5
Ko, M.6
McLoughlin, E.M.7
Brudno, Y.8
Mahapatra, S.9
Kapranov, P.10
Tahiliani, M.11
Daley, G.Q.12
Liu, X.S.13
Ecker, J.R.14
Milos, P.M.15
Agarwal, S.16
Rao, A.17
-
8
-
-
79956323623
-
Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation
-
Ficz G., Branco M.R., Seisenberger S., Santos F., Krueger F., Hore T.A., Marques C.J., Andrews S., Reik W. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011, 473:398-402.
-
(2011)
Nature
, vol.473
, pp. 398-402
-
-
Ficz, G.1
Branco, M.R.2
Seisenberger, S.3
Santos, F.4
Krueger, F.5
Hore, T.A.6
Marques, C.J.7
Andrews, S.8
Reik, W.9
-
9
-
-
0037350661
-
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)
-
Lorsbach R.B., Moore J., Mathew S., Raimondi S.C., Mukatira S.T., Downing J.R. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 2003, 17:637-641.
-
(2003)
Leukemia
, vol.17
, pp. 637-641
-
-
Lorsbach, R.B.1
Moore, J.2
Mathew, S.3
Raimondi, S.C.4
Mukatira, S.T.5
Downing, J.R.6
-
10
-
-
78650175023
-
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
-
Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S., An J., Lamperti E.D., Koh K.P., Ganetzky R., Liu X.S., Aravind L., Agarwal S., Maciejewski J.P., Rao A. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843.
-
(2010)
Nature
, vol.468
, pp. 839-843
-
-
Ko, M.1
Huang, Y.2
Jankowska, A.M.3
Pape, U.J.4
Tahiliani, M.5
Bandukwala, H.S.6
An, J.7
Lamperti, E.D.8
Koh, K.P.9
Ganetzky, R.10
Liu, X.S.11
Aravind, L.12
Agarwal, S.13
Maciejewski, J.P.14
Rao, A.15
-
11
-
-
67649876132
-
Acquired mutations in TET2 are common in myelodysplastic syndromes
-
Langemeijer S.M., Kuiper R.P., Berends M., Knops R., Aslanyan M.G., Massop M., Stevens-Linders E., van Hoogen P., van Kessel A.G., Raymakers R.A., Kamping E.J., Verhoef G.E., Verburgh E., Hagemeijer A., Vandenberghe P., de Witte T., van der Reijden B.A., Jansen J.H. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Genet. 2009, 41:838-842.
-
(2009)
Nat. Genet.
, vol.41
, pp. 838-842
-
-
Langemeijer, S.M.1
Kuiper, R.P.2
Berends, M.3
Knops, R.4
Aslanyan, M.G.5
Massop, M.6
Stevens-Linders, E.7
van Hoogen, P.8
van Kessel, A.G.9
Raymakers, R.A.10
Kamping, E.J.11
Verhoef, G.E.12
Verburgh, E.13
Hagemeijer, A.14
Vandenberghe, P.15
de Witte, T.16
van der Reijden, B.A.17
Jansen, J.H.18
-
12
-
-
78149454504
-
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value
-
Smith A.E., Mohamedali A.M., Kulasekararaj A., Lim Z., Gaken J., Lea N.C., Przychodzen B., Mian S.A., Nasser E.E., Shooter C., Westwood N.B., Strupp C., Gattermann N., Maciejewski J.P., Germing U., Mufti G.J. Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Blood 2010, 116:3923-3932.
-
(2010)
Blood
, vol.116
, pp. 3923-3932
-
-
Smith, A.E.1
Mohamedali, A.M.2
Kulasekararaj, A.3
Lim, Z.4
Gaken, J.5
Lea, N.C.6
Przychodzen, B.7
Mian, S.A.8
Nasser, E.E.9
Shooter, C.10
Westwood, N.B.11
Strupp, C.12
Gattermann, N.13
Maciejewski, J.P.14
Germing, U.15
Mufti, G.J.16
-
13
-
-
79960064353
-
TET2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
-
Moran-Crusio K., Reavie L., Shih A., Abdel-Wahab O., Ndiaye-Lobry D., Lobry C., Figueroa M.E., Vasanthakumar A., Patel J., Zhao X., Perna F., Pandey S., Madzo J., Song C., Dai Q., He C., Ibrahim S., Beran M., Zavadil J., Nimer S.D., Melnick A., Godley L.A., Aifantis I., Levine R.L. TET2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011, 20:11-24.
-
(2011)
Cancer Cell
, vol.20
, pp. 11-24
-
-
Moran-Crusio, K.1
Reavie, L.2
Shih, A.3
Abdel-Wahab, O.4
Ndiaye-Lobry, D.5
Lobry, C.6
Figueroa, M.E.7
Vasanthakumar, A.8
Patel, J.9
Zhao, X.10
Perna, F.11
Pandey, S.12
Madzo, J.13
Song, C.14
Dai, Q.15
He, C.16
Ibrahim, S.17
Beran, M.18
Zavadil, J.19
Nimer, S.D.20
Melnick, A.21
Godley, L.A.22
Aifantis, I.23
Levine, R.L.24
more..
-
14
-
-
80052285127
-
Deletion of TET2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
-
Li Z., Cai X., Cai C.L., Wang J., Zhang W., Petersen B.E., Yang F.C., Xu M. Deletion of TET2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 2011, 118:4509-4518.
-
(2011)
Blood
, vol.118
, pp. 4509-4518
-
-
Li, Z.1
Cai, X.2
Cai, C.L.3
Wang, J.4
Zhang, W.5
Petersen, B.E.6
Yang, F.C.7
Xu, M.8
-
15
-
-
80052284526
-
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
-
Ko M., Bandukwala H.S., An J., Lamperti E.D., Thompson E.C., Hastie R., Tsangaratou A., Rajewsky K., Koralov S.B., Rao A. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 2011, 108:14566-14571.
-
(2011)
Proc. Natl. Acad. Sci. USA
, vol.108
, pp. 14566-14571
-
-
Ko, M.1
Bandukwala, H.S.2
An, J.3
Lamperti, E.D.4
Thompson, E.C.5
Hastie, R.6
Tsangaratou, A.7
Rajewsky, K.8
Koralov, S.B.9
Rao, A.10
-
16
-
-
79960062301
-
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis
-
Quivoron C., Couronne L., Della Valle V., Lopez C.K., Plo I., Wagner-Ballon O., Do Cruzeiro M., Delhommeau F., Arnulf B., Stern M.H., Godley L., Opolon P., Tilly H., Solary E., Duffourd Y., Dessen P., Merle-Beral H., Nguyen-Khac F., Fontenay M., Vainchenker W., Bastard C., Mercher T., Bernard O.A. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011, 20:25-38.
-
(2011)
Cancer Cell
, vol.20
, pp. 25-38
-
-
Quivoron, C.1
Couronne, L.2
Della Valle, V.3
Lopez, C.K.4
Plo, I.5
Wagner-Ballon, O.6
Do Cruzeiro, M.7
Delhommeau, F.8
Arnulf, B.9
Stern, M.H.10
Godley, L.11
Opolon, P.12
Tilly, H.13
Solary, E.14
Duffourd, Y.15
Dessen, P.16
Merle-Beral, H.17
Nguyen-Khac, F.18
Fontenay, M.19
Vainchenker, W.20
Bastard, C.21
Mercher, T.22
Bernard, O.A.23
more..
-
17
-
-
79961139741
-
TET1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development
-
Dawlaty M.M., Ganz K., Powell B.E., Hu Y.C., Markoulaki S., Cheng A.W., Gao Q., Kim J., Choi S.W., Page D.C., Jaenisch R. TET1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 2011, 9:166-175.
-
(2011)
Cell Stem Cell
, vol.9
, pp. 166-175
-
-
Dawlaty, M.M.1
Ganz, K.2
Powell, B.E.3
Hu, Y.C.4
Markoulaki, S.5
Cheng, A.W.6
Gao, Q.7
Kim, J.8
Choi, S.W.9
Page, D.C.10
Jaenisch, R.11
-
18
-
-
72049125350
-
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
-
Dang L., White D.W., Gross S., Bennett B.D., Bittinger M.A., Driggers E.M., Fantin V.R., Jang H.G., Jin S., Keenan M.C., Marks K.M., Prins R.M., Ward P.S., Yen K.E., Liau L.M., Rabinowitz J.D., Cantley L.C., Thompson C.B., Vander Heiden M.G., Su S.M. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009, 462:739-744.
-
(2009)
Nature
, vol.462
, pp. 739-744
-
-
Dang, L.1
White, D.W.2
Gross, S.3
Bennett, B.D.4
Bittinger, M.A.5
Driggers, E.M.6
Fantin, V.R.7
Jang, H.G.8
Jin, S.9
Keenan, M.C.10
Marks, K.M.11
Prins, R.M.12
Ward, P.S.13
Yen, K.E.14
Liau, L.M.15
Rabinowitz, J.D.16
Cantley, L.C.17
Thompson, C.B.18
Vander Heiden, M.G.19
Su, S.M.20
more..
-
19
-
-
78650019179
-
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
-
Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., Li Y., Bhagwat N., Vasanthakumar A., Fernandez H.F., Tallman M.S., Sun Z., Wolniak K., Peeters J.K., Liu W., Choe S.E., Fantin V.R., Paietta E., Lowenberg B., Licht J.D., Godley L.A., Delwel R., Valk P.J., Thompson C.B., Levine R.L., Melnick A. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567.
-
(2010)
Cancer Cell
, vol.18
, pp. 553-567
-
-
Figueroa, M.E.1
Abdel-Wahab, O.2
Lu, C.3
Ward, P.S.4
Patel, J.5
Shih, A.6
Li, Y.7
Bhagwat, N.8
Vasanthakumar, A.9
Fernandez, H.F.10
Tallman, M.S.11
Sun, Z.12
Wolniak, K.13
Peeters, J.K.14
Liu, W.15
Choe, S.E.16
Fantin, V.R.17
Paietta, E.18
Lowenberg, B.19
Licht, J.D.20
Godley, L.A.21
Delwel, R.22
Valk, P.J.23
Thompson, C.B.24
Levine, R.L.25
Melnick, A.26
more..
-
20
-
-
79955547561
-
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
-
Chowdhury R., Yeoh K.K., Tian Y.M., Hillringhaus L., Bagg E.A., Rose N.R., Leung I.K., Li X.S., Woon E.C., Yang M., McDonough M.A., King O.N., Clifton I.J., Klose R.J., Claridge T.D., Ratcliffe P.J., Schofield C.J., Kawamura A. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 2011, 12:463-469.
-
(2011)
EMBO Rep.
, vol.12
, pp. 463-469
-
-
Chowdhury, R.1
Yeoh, K.K.2
Tian, Y.M.3
Hillringhaus, L.4
Bagg, E.A.5
Rose, N.R.6
Leung, I.K.7
Li, X.S.8
Woon, E.C.9
Yang, M.10
McDonough, M.A.11
King, O.N.12
Clifton, I.J.13
Klose, R.J.14
Claridge, T.D.15
Ratcliffe, P.J.16
Schofield, C.J.17
Kawamura, A.18
-
21
-
-
37349074531
-
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD
-
Pasini B., McWhinney S.R., Bei T., Matyakhina L., Stergiopoulos S., Muchow M., Boikos S.A., Ferrando B., Pacak K., Assie G., Baudin E., Chompret A., Ellison J.W., Briere J.J., Rustin P., Gimenez-Roqueplo A.P., Eng C., Carney J.A., Stratakis C.A. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur. J. Hum. Genet. 2008, 16:79-88.
-
(2008)
Eur. J. Hum. Genet.
, vol.16
, pp. 79-88
-
-
Pasini, B.1
McWhinney, S.R.2
Bei, T.3
Matyakhina, L.4
Stergiopoulos, S.5
Muchow, M.6
Boikos, S.A.7
Ferrando, B.8
Pacak, K.9
Assie, G.10
Baudin, E.11
Chompret, A.12
Ellison, J.W.13
Briere, J.J.14
Rustin, P.15
Gimenez-Roqueplo, A.P.16
Eng, C.17
Carney, J.A.18
Stratakis, C.A.19
-
22
-
-
33745234207
-
Increased risk of cancer in patients with fumarate hydratase germline mutation
-
Lehtonen H.J., Kiuru M., Ylisaukko-Oja S.K., Salovaara R., Herva R., Koivisto P.A., Vierimaa O., Aittomaki K., Pukkala E., Launonen V., Aaltonen L.A. Increased risk of cancer in patients with fumarate hydratase germline mutation. J. Med. Genet. 2006, 43:523-526.
-
(2006)
J. Med. Genet.
, vol.43
, pp. 523-526
-
-
Lehtonen, H.J.1
Kiuru, M.2
Ylisaukko-Oja, S.K.3
Salovaara, R.4
Herva, R.5
Koivisto, P.A.6
Vierimaa, O.7
Aittomaki, K.8
Pukkala, E.9
Launonen, V.10
Aaltonen, L.A.11
-
23
-
-
34047255064
-
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates
-
Hewitson K.S., Lienard B.M., McDonough M.A., Clifton I.J., Butler D., Soares A.S., Oldham N.J., McNeill L.A., Schofield C.J. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J. Biol. Chem. 2007, 282:3293-3301.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 3293-3301
-
-
Hewitson, K.S.1
Lienard, B.M.2
McDonough, M.A.3
Clifton, I.J.4
Butler, D.5
Soares, A.S.6
Oldham, N.J.7
McNeill, L.A.8
Schofield, C.J.9
-
24
-
-
17944375360
-
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
-
Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 107:43-54.
-
(2001)
Cell
, vol.107
, pp. 43-54
-
-
Epstein, A.C.1
Gleadle, J.M.2
McNeill, L.A.3
Hewitson, K.S.4
O'Rourke, J.5
Mole, D.R.6
Mukherji, M.7
Metzen, E.8
Wilson, M.I.9
Dhanda, A.10
Tian, Y.M.11
Masson, N.12
Hamilton, D.L.13
Jaakkola, P.14
Barstead, R.15
Hodgkin, J.16
Maxwell, P.H.17
Pugh, C.W.18
Schofield, C.J.19
Ratcliffe, P.J.20
more..
-
25
-
-
0037068433
-
AlkB-mediated oxidative demethylation reverses DNA damage in E. coli
-
Falnes P.O., Johansen R.F., Seeberg E. AlkB-mediated oxidative demethylation reverses DNA damage in E. coli. Nature 2002, 419:178-182.
-
(2002)
Nature
, vol.419
, pp. 178-182
-
-
Falnes, P.O.1
Johansen, R.F.2
Seeberg, E.3
-
26
-
-
0037068446
-
Oxidative demethylation by E. coli AlkB directly reverts DNA base damage
-
Trewick S.C., Henshaw T.F., Hausinger R.P., Lindahl T., Sedgwick B. Oxidative demethylation by E. coli AlkB directly reverts DNA base damage. Nature 2002, 419:174-178.
-
(2002)
Nature
, vol.419
, pp. 174-178
-
-
Trewick, S.C.1
Henshaw, T.F.2
Hausinger, R.P.3
Lindahl, T.4
Sedgwick, B.5
-
27
-
-
4644343184
-
Demethylation of 3-methylthymine in DNA by bacterial and human DNA dioxygenases
-
Koivisto P., Robins P., Lindahl T., Sedgwick B. Demethylation of 3-methylthymine in DNA by bacterial and human DNA dioxygenases. J. Biol. Chem. 2004, 279:40470-40474.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 40470-40474
-
-
Koivisto, P.1
Robins, P.2
Lindahl, T.3
Sedgwick, B.4
-
28
-
-
77951623073
-
Crystal structure of the FTO protein reveals basis for its substrate specificity
-
Han Z., Niu T., Chang J., Lei X., Zhao M., Wang Q., Cheng W., Wang J., Feng Y., Chai J. Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature 2010, 464:1205-1209.
-
(2010)
Nature
, vol.464
, pp. 1205-1209
-
-
Han, Z.1
Niu, T.2
Chang, J.3
Lei, X.4
Zhao, M.5
Wang, Q.6
Cheng, W.7
Wang, J.8
Feng, Y.9
Chai, J.10
-
29
-
-
77950476036
-
5-methylcytosine in RNA: detection, enzymatic formation and biological functions
-
Motorin Y., Lyko F., Helm M. 5-methylcytosine in RNA: detection, enzymatic formation and biological functions. Nucleic Acids Res. 2010, 38:1415-1430.
-
(2010)
Nucleic Acids Res.
, vol.38
, pp. 1415-1430
-
-
Motorin, Y.1
Lyko, F.2
Helm, M.3
-
30
-
-
79955538247
-
Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain
-
Guo J.U., Su Y., Zhong C., Ming G.L., Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011, 145:423-434.
-
(2011)
Cell
, vol.145
, pp. 423-434
-
-
Guo, J.U.1
Su, Y.2
Zhong, C.3
Ming, G.L.4
Song, H.5
-
31
-
-
33645891676
-
Structural studies on 2-oxoglutarate oxygenases and related double-stranded beta-helix fold proteins
-
Clifton I.J., McDonough M.A., Ehrismann D., Kershaw N.J., Granatino N., Schofield C.J. Structural studies on 2-oxoglutarate oxygenases and related double-stranded beta-helix fold proteins. J. Inorg. Biochem. 2006, 100:644-669.
-
(2006)
J. Inorg. Biochem.
, vol.100
, pp. 644-669
-
-
Clifton, I.J.1
McDonough, M.A.2
Ehrismann, D.3
Kershaw, N.J.4
Granatino, N.5
Schofield, C.J.6
-
32
-
-
0031574232
-
The 2-His-1-carboxylate facial triad. an emerging motif in mononuclear non-heme iron(II) enzymes.
-
Hegg E.L., Que L. The 2-His-1-carboxylate facial triad. an emerging motif in mononuclear non-heme iron(II) enzymes. Eur. J. Biochem. 1997, 250:625-629.
-
(1997)
Eur. J. Biochem.
, vol.250
, pp. 625-629
-
-
Hegg, E.L.1
Que, L.2
-
33
-
-
39449130475
-
Versatility of biological non-heme Fe(II) centers in oxygen activation reactions
-
Kovaleva E.G., Lipscomb J.D. Versatility of biological non-heme Fe(II) centers in oxygen activation reactions. Nat. Chem. Biol. 2008, 4:186-193.
-
(2008)
Nat. Chem. Biol.
, vol.4
, pp. 186-193
-
-
Kovaleva, E.G.1
Lipscomb, J.D.2
-
34
-
-
80052495940
-
TET-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA
-
He Y.F., Li B.Z., Li Z., Liu P., Wang Y., Tang Q., Ding J., Jia Y., Chen Z., Li L., Sun Y., Li X., Dai Q., Song C.X., Zhang K., He C., Xu G.L. TET-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
-
(2011)
Science
, vol.333
, pp. 1303-1307
-
-
He, Y.F.1
Li, B.Z.2
Li, Z.3
Liu, P.4
Wang, Y.5
Tang, Q.6
Ding, J.7
Jia, Y.8
Chen, Z.9
Li, L.10
Sun, Y.11
Li, X.12
Dai, Q.13
Song, C.X.14
Zhang, K.15
He, C.16
Xu, G.L.17
-
35
-
-
80052461558
-
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
-
Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C., Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
-
(2011)
Science
, vol.333
, pp. 1300-1303
-
-
Ito, S.1
Shen, L.2
Dai, Q.3
Wu, S.C.4
Collins, L.B.5
Swenberg, J.A.6
He, C.7
Zhang, Y.8
-
36
-
-
77956217067
-
Regulation of the HIF-1alpha level is essential for hematopoietic stem cells
-
Takubo K., Goda N., Yamada W., Iriuchishima H., Ikeda E., Kubota Y., Shima H., Johnson R.S., Hirao A., Suematsu M., Suda T. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010, 7:391-402.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 391-402
-
-
Takubo, K.1
Goda, N.2
Yamada, W.3
Iriuchishima, H.4
Ikeda, E.5
Kubota, Y.6
Shima, H.7
Johnson, R.S.8
Hirao, A.9
Suematsu, M.10
Suda, T.11
-
37
-
-
84855908582
-
Hypoxia induced expression of histone lysine demethylases: implications in oxygen-dependent retinal neovascular diseases
-
Ponnaluri V.K., Vadlapatla R.K., Vavilala D.T., Pal D., Mitra A.K., Mukherji M. Hypoxia induced expression of histone lysine demethylases: implications in oxygen-dependent retinal neovascular diseases. Biochem. Biophys. Res. Commun. 2011, 415:373-377.
-
(2011)
Biochem. Biophys. Res. Commun.
, vol.415
, pp. 373-377
-
-
Ponnaluri, V.K.1
Vadlapatla, R.K.2
Vavilala, D.T.3
Pal, D.4
Mitra, A.K.5
Mukherji, M.6
-
38
-
-
33846315497
-
Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay
-
Ehrismann D., Flashman E., Genn D.N., Mathioudakis N., Hewitson K.S., Ratcliffe P.J., Schofield C.J. Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. Biochem. J. 2007, 401:227-234.
-
(2007)
Biochem. J.
, vol.401
, pp. 227-234
-
-
Ehrismann, D.1
Flashman, E.2
Genn, D.N.3
Mathioudakis, N.4
Hewitson, K.S.5
Ratcliffe, P.J.6
Schofield, C.J.7
-
39
-
-
0043234538
-
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
-
Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 2003, 278:30772-30780.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 30772-30780
-
-
Hirsila, M.1
Koivunen, P.2
Gunzler, V.3
Kivirikko, K.I.4
Myllyharju, J.5
-
40
-
-
1642315195
-
Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases
-
Koivunen P., Hirsila M., Gunzler V., Kivirikko K.I., Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J. Biol. Chem. 2004, 279:9899-9904.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 9899-9904
-
-
Koivunen, P.1
Hirsila, M.2
Gunzler, V.3
Kivirikko, K.I.4
Myllyharju, J.5
-
41
-
-
84861924083
-
Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases
-
Vavilala D.T., Chaithanya Ponnaluri V.K., Vadlapatla R.K., Pal D., Mitra A.K., Mukherji M. Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases. Biochem. Biophys. Res. Commun. 2012.
-
(2012)
Biochem. Biophys. Res. Commun.
-
-
Vavilala, D.T.1
Chaithanya Ponnaluri, V.K.2
Vadlapatla, R.K.3
Pal, D.4
Mitra, A.K.5
Mukherji, M.6
-
42
-
-
84868593544
-
Kinetic analysis of iron-dependent histone demethylases: alpha-ketoglutarate substrate inhibition and potential relevance to the regulation of histone demethylation in cancer cells
-
Cascella B., Mirica L.M. Kinetic analysis of iron-dependent histone demethylases: alpha-ketoglutarate substrate inhibition and potential relevance to the regulation of histone demethylation in cancer cells. Biochemistry 2012, 51:8699-8701.
-
(2012)
Biochemistry
, vol.51
, pp. 8699-8701
-
-
Cascella, B.1
Mirica, L.M.2
-
43
-
-
83755178091
-
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability
-
Wise D.R., Ward P.S., Shay J.E., Cross J.R., Gruber J.J., Sachdeva U.M., Platt J.M., DeMatteo R.G., Simon M.C., Thompson C.B. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. USA 2011, 108:19611-19616.
-
(2011)
Proc. Natl. Acad. Sci. USA
, vol.108
, pp. 19611-19616
-
-
Wise, D.R.1
Ward, P.S.2
Shay, J.E.3
Cross, J.R.4
Gruber, J.J.5
Sachdeva, U.M.6
Platt, J.M.7
DeMatteo, R.G.8
Simon, M.C.9
Thompson, C.B.10
|